A Cross-sectional Study Among Patients in Canada to Assess Awareness and Knowledge of the Fibristal Patient Alert Card

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/37707
• EU PAS number:
  EUPAS36199
• Study ID:
  37707
• Official title and acronym:
  A Cross-sectional Study Among Patients in Canada to Assess Awareness and Knowledge of the Fibristal Patient Alert Card
• DARWIN EU® study:
  No
• Study countries:
  Canada
• Study description:
  This Cross-sectional study will assess patients’ receipt and use of the Fibristal Patient Alert Card, and knowledge of the key messages included in Fibristal Patient Alert Card. This study was cancelled before any data collection due to business reasons.
• Study status:
  Finalised

Research institutions and networks

Institutions

ICON Commercialisation & Outcomes

Germany

Ireland

Study timelines

Date when funding contract was signed

Planned: 21/04/2019

Actual: 21/04/2019

Study start date

Planned: 31/10/2020

Actual: 28/09/2020

Date of final study report

Planned: 30/06/2021

Actual: 28/09/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Allergan

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

CMO-EPI-WH-0626